Participate in a Study
hello world!
SCIENCE 37

The Science 37 Metasite™:
The Site that Visits the Patient.

Study enrollment rates have declined by more than 50% from pre-pandemic levels. To meet today’s challenges, the Science 37 Metasite™ expands your access to untapped patient populations and liberates you from geography and diversity limitations. With a site that visits the patient, you’ll accelerate study recruitment and enrollment, while delivering high-quality data.
Get Started

Expanded Access to Patients Accelerates and
Enhances your Clinical Trial.

There’s no substitute for speed. Compared to traditional site-based studies, the Science 37 Metasite™ accelerates your study’s recruitment and start up, while enabling greater patient retention and inclusivity.

Trials Without Science 37

Limited Participation: Only 8% of patients participate in traditional clinical research.

Slower Execution: Average start-up time is 31.4 weeks, with 80% delayed from enrollment.

Poor Retention: On average, trials have a 70% retention rate.

Limited Diversity: Only an average of 14% non-white representation.

Trials With the
Science 37 Metasite™

Access to the remaining 90%+ of the patient population.

More than 2x faster trial startup— 
entire countries launched in a single day.

96%+ patient retention.

3x greater diversity.

Recruitment Engine: Centralized Patient Engagement Ensures 100% Follow Up.

The Science 37 Metasite™ leverages real-world prevalence data to deliver data-driven feasibility assessments and uses an omni-channel recruitment approach to select the best channel for reaching receptive patients. Interactive screeners and a Centralized Patient Engagement Center drive high-efficiency enrollment so that no patient is lost to follow up.
Learn More

Clear, Consistent Experiences Drive Compliance and Data Quality.

In the skilled hands of the Science 37 team, every step of the patient journey is a high-touch experience that drives study conduct excellence. The Metasite™’s easy-to-follow and standardized processes deliver greater consistency, compliance, and data accuracy—ensuring reliability for regulators according to GCP standards.

The Patient Experience

From enrollment through study completion, the patient follows intuitive, app-based processes using their everyday mobile device. Embedded videos and user prompts guide them. The patient’s entire journey is supported by a unified platform and the Science 37 team.

The Investigator Experience

A digital schedule of assessments gives total visibility into where each patient is in their individual journey. The Metasite™ eliminates ambiguity and ensures consistency and compliance across every participant.

The Patient Experience

From enrollment through study completion, the patient follows intuitive, app-based processes using their everyday mobile device. Embedded videos and user prompts guide them. The patient’s entire journey is supported by a unified platform and the Science 37 team.

The Investigator Experience

A digital schedule of assessments gives total visibility into where each patient is in their individual journey. The Metasite™ eliminates ambiguity and ensures consistency and compliance across every participant.

Eliminate the Need for Data Re-Entry.

The moment a study facilitator enters data and hits “submit”, the data is captured in the system and reflected in the patient journey without the need for manual re-entry.
A Site that Follows the Patient, Eliminating Location Restrictions.
At-Home
Local Community Providers
Research Sites

Deliver the Full Spectrum of Trial Activities with the Science 37 Metasite™.

The Metasite™ drives excellence and flexibility throughout the clinical trial.
Learn More

Proof the Science 37 Metasite™
Is Working on Every Level.

Sponsors and CROs who partner with Science 37 get access to the full range of Metasite™ capabilities at scale.

150+

Trials Launched

3x

More Diversity than Traditional Sites

33M+

Patients Accesible

34k+

Physician Providers
(contracted for research)

The Science 37 Metasite™ in Action.

Science 37 Accelerates
Timelines and Expands Reach in Infectious Disease Study.

Sponsors and CROs are Using Science 37 to Expand Access to Clinical Trials Globally.

  • “Science 37 delivers a model that truly supports patient preference—providing access through the site or through a DCT model. The patient’s choice is front and center.”
    Clinical Trial Sponsor
  • “Science 37 allows us to enroll patients who don’t traditionally participate in trials, decreasing burden on patients and site, improving diversity and reach.”
    Clinical Trial Sponsor
  • “[The Science 37] Metasite™ strategy complements the conventional site mix to accelerate the recruitment of patients in remote locations and in underrepresented communities.”
    IDC Real-World Evidence, Social Determinants of Health, and Digital Biomarkers in Driving Patient Recruitment, #US50382823, March 2023
  • “Science 37 places a significant emphasis on training. Healthcare staff are trained on the platform used in clinical trials, ensuring that when the patient and provider come into contact during any DCT, the patient experience is easy, and the data collected is accurate.”
    GlobalData
SCIENCE 37

Connect with a Science 37 Solutions Expert Today.

Contact us today to learn more about how we can help you.
Learn More
© 2025 Science 37 | All Rights Reserved